Fingerprint
Dive into the research topics where naofumi hara is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Prompt Diagnosis of Ascites and Dramatic Effect of Alectinib for Advanced Lung Adenocarcinoma Harboring EML4-ALK Fusion
Baba, T., Inoue, H., Matsuoka, H., Kyakuno, M., Yoshinaga, Y., Takeguchi, T., Fujiwara, M., Yamada, K., Nakamura, E., Morita, A., Hara, N., Ninomiya, K., Higo, H., Fujii, M., Ichihara, E., Rai, K., Ohashi, K., Hotta, K., Tabata, M. & Maeda, Y. & 2 others, , Dec 1 2025, In: Internal Medicine. 64, 23, p. 3413-3418 6 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation
Okawa, S., Tomida, S., Kuribayashi, T., Nishimura, J., Nakasuka, T., Hirabae, A., Hara, N., Inoue, H., Makimoto, G., Ninomiya, K., Rai, K., Ichihara, E., Hotta, K., Tabata, M., Maeda, Y., Kiura, K. & Ohashi, K., Nov 1 2025, In: Molecular cancer therapeutics. 24, 11, p. 1763-1774 12 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines
Nishi, T., Morita, A., Hara, N., Makimoto, G., Ninomiya, K., Fujii, M., Rai, K., Ohashi, K., Hotta, K., Tabata, M., Togashi, Y., Maeda, Y. & Ichihara, E., Mar 2025, In: Lung Cancer. 201, 108415.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol
Nakamura, N., Makimoto, G., Tanaka, T., Kato, Y., Oze, I., Kozuki, T., Yokoyama, T., Ichikawa, H., Kuyama, S., Hara, N., Maeda, Y. & Hotta, K., Sept 2024, In: Respiratory Investigation. 62, 5, p. 897-900 4 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer
Morita, A., Ichihara, E., Inoue, K., Fujiwara, K., Yokoyama, T., Harada, D., Ando, C., Kano, H., Oda, N., Tamura, T., Ochi, N., Kawai, H., Inoue, M., Hara, N., Fujimoto, N., Ichikawa, H., Oze, I., Hotta, K., Maeda, Y. & Kiura, K., May 1 2024, In: International Journal of Cancer. 154, 9, p. 1607-1615 9 p.Research output: Contribution to journal › Article › peer-review
21 Link opens in a new tab Citations (Scopus)